These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

96 related items for PubMed ID: 8821546

  • 1. Inhibition of prostanoid formation in intact cells by 2,5-di-(tert-butyl)-1,4-benzohydroquinone, a blocker of Ca(2+)-ATPases.
    Leis HJ, Zach D, Huber E, Ziermann L, Gleispach H, Windischhofer W.
    Br J Pharmacol; 1996 Feb; 117(3):540-544. PubMed ID: 8821546
    [Abstract] [Full Text] [Related]

  • 2. On the inhibition of prostanoid formation by SK&F 96365, a blocker of receptor-operated calcium entry.
    Leis HJ, Zach D, Huber E, Ziermann L, Gleispach H, Windischhofer W.
    Br J Pharmacol; 1995 Feb; 114(3):598-601. PubMed ID: 7735686
    [Abstract] [Full Text] [Related]

  • 3. The mechanism of rabbit platelet aggregation induced by 2,5-di-(tert-butyl)-1,4-benzohydroquinone, an inhibitor of endoplasmic reticulum Ca2+-ATPase.
    Furukawa KI, Matsuzawa M, Tsurufuji S, Watanabe K, Ohizumi Y.
    Jpn J Pharmacol; 1997 Nov; 75(3):295-8. PubMed ID: 9434262
    [Abstract] [Full Text] [Related]

  • 4. Different effects of endothelin-3 on the Ca2+ discharge induced by agonists and Ca(2+)-ATPase inhibitors in human platelets.
    Astarie-Dequeker C, Korichneva I, Devynck MA.
    Br J Pharmacol; 1995 Jan; 114(2):524-30. PubMed ID: 7881751
    [Abstract] [Full Text] [Related]

  • 5. Effect of cytochrome P-450 inhibitors econazole, bifonazole and clotrimazole on prostanoid formation.
    Köfeler HC, Fauler G, Windischhofer W, Leis HJ.
    Br J Pharmacol; 2000 Jul; 130(6):1241-6. PubMed ID: 10903961
    [Abstract] [Full Text] [Related]

  • 6. Ca2+ release from platelet intracellular stores by thapsigargin and 2,5-di-(t-butyl)-1,4-benzohydroquinone: relationship to Ca2+ pools and relevance in platelet activation.
    Authi KS, Bokkala S, Patel Y, Kakkar VV, Munkonge F.
    Biochem J; 1993 Aug 15; 294 ( Pt 1)(Pt 1):119-26. PubMed ID: 8363562
    [Abstract] [Full Text] [Related]

  • 7. Calcium involvement in aminophospholipid exposure and microparticle formation during platelet activation: a study using Ca2+-ATPase inhibitors.
    Dachary-Prigent J, Pasquet JM, Freyssinet JM, Nurden AT.
    Biochemistry; 1995 Sep 12; 34(36):11625-34. PubMed ID: 7547894
    [Abstract] [Full Text] [Related]

  • 8. Calcium mobilization in human platelets by receptor agonists and calcium-ATPase inhibitors.
    Brüne B, Ullrich V.
    FEBS Lett; 1991 Jun 17; 284(1):1-4. PubMed ID: 1647969
    [Abstract] [Full Text] [Related]

  • 9. An antithrombotic agent, NQ301, inhibits thromboxane A2 receptor and synthase activity in rabbit platelets.
    Jin YR, Cho MR, Lee KS, Lee JJ, Lim Y, Han XH, Oh KW, Hong JT, Yoo HS, Yun YP.
    Basic Clin Pharmacol Toxicol; 2005 Sep 17; 97(3):162-7. PubMed ID: 16128910
    [Abstract] [Full Text] [Related]

  • 10. Heterogeneous increases of cytoplasmic calcium: distinct effects on down-regulation of cell surface sodium channels and sodium channel subunit mRNA levels.
    Shiraishi S, Shibuya I, Uezono Y, Yokoo H, Toyohira Y, Yamamoto R, Yanagita T, Kobayashi H, Wada A.
    Br J Pharmacol; 2001 Apr 17; 132(7):1455-66. PubMed ID: 11264239
    [Abstract] [Full Text] [Related]

  • 11. A role for protein phosphorylation in modulating Ca2+ elevation in rabbit platelets treated with thapsigargin.
    Murphy CT, Bullock AJ, Westwick J.
    Biochem J; 1996 Jan 01; 313 ( Pt 1)(Pt 1):83-9. PubMed ID: 8546714
    [Abstract] [Full Text] [Related]

  • 12. Regulation of extracellular calcium entry in endothelial cells: role of intracellular calcium pool.
    Dolor RJ, Hurwitz LM, Mirza Z, Strauss HC, Whorton AR.
    Am J Physiol; 1992 Jan 01; 262(1 Pt 1):C171-81. PubMed ID: 1531101
    [Abstract] [Full Text] [Related]

  • 13. Influence of authentic nitric oxide on basal cytosolic [Ca2+] and Ca2+ release from internal stores in human platelets.
    Le Quan Sang KH, Lantoine F, Devynck MA.
    Br J Pharmacol; 1996 Dec 01; 119(7):1361-6. PubMed ID: 8968544
    [Abstract] [Full Text] [Related]

  • 14. The inhibitory effects of mercaptoalkylguanidines on cyclo-oxygenase activity.
    Zingarelli B, Southan GJ, Gilad E, O'Connor M, Salzman AL, Szabó C.
    Br J Pharmacol; 1997 Feb 01; 120(3):357-66. PubMed ID: 9031736
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Calcium influx is a determining factor of calpain activation and microparticle formation in platelets.
    Pasquet JM, Dachary-Prigent J, Nurden AT.
    Eur J Biochem; 1996 Aug 01; 239(3):647-54. PubMed ID: 8774708
    [Abstract] [Full Text] [Related]

  • 17. The cyclo-oxygenase-dependent regulation of rabbit vein contraction: evidence for a prostaglandin E2-mediated relaxation.
    Rouaud C, Delaforge M, Anger-Leroy M, Le Filliatre G, Finet M, Hanf R.
    Br J Pharmacol; 1999 Jan 01; 126(1):35-44. PubMed ID: 10051118
    [Abstract] [Full Text] [Related]

  • 18. Effect of a potent cyclooxygenase inhibitor, 5-ethyl-4-methoxy-2-phenylquinoline (KTC-5), on human platelets.
    Liao CH, Liao CH, Chang YL, Guh JH, Kuo SC, Huang LJ, Teng CM.
    J Pharm Pharmacol; 2002 Jul 01; 54(7):967-74. PubMed ID: 12162716
    [Abstract] [Full Text] [Related]

  • 19. Two classes of agonist-sensitive Ca2+ stores in platelets, as identified by their differential sensitivity to 2,5-di-(tert-butyl)-1,4-benzohydroquinone and thapsigargin.
    Cavallini L, Coassin M, Alexandre A.
    Biochem J; 1995 Sep 01; 310 ( Pt 2)(Pt 2):449-52. PubMed ID: 7654182
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.